Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcoma
Author:
Affiliation:
1. Duke University Medical Center Durham North Carolina USA
Publisher
Wiley
Subject
Oncology,Hematology,Pediatrics, Perinatology and Child Health
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29084
Reference77 articles.
1. Treatment pathway of bone sarcoma in children, adolescents, and young adults
2. Osteosarcoma: a comprehensive review
3. Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
4. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
5. LeaveyP KrailoM DuBoisS et al.A phase III randomized trial of adding vincristine‐topotecan‐cyclophosphamide (VTC) to standard chemotherapy in initial treatment of non‐metastatic Ewing sarcoma – a report from the Children's Oncology Group. 2019 Connective Tissue Oncology Society Annual Meeting; November 16 2019; Tokyo Japan.
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Proteomics and genomics insights on malignant osteosarcoma;Functional Proteomics;2024
2. Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa;Journal of Bone Oncology;2023-12
3. CB65 and novel CB65 liposomal system suppress MG63 and Saos-2 osteosarcoma cell growth in vitro;Journal of Liposome Research;2023-09-23
4. Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumors;Pediatric Blood & Cancer;2023-08-29
5. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth;Cell Death & Disease;2023-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3